Marker Therapeutics Inc (MRKR)

[shub]

Thanks Burrhead.
Small, cash flow negative bios like TPIV are plagued by loud mouths attempting to work the short term SP for petty profits.
By undermining the Tapimmune shareprice, they undermine the companies' ability to finance the necessary research and clinical trials.
The fact that the company is earnestly laboring away, working hard to end the agonizing, tragic deaths of thousands of victims,
bothers those SP parasites not-at-all!